{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:23:51Z","timestamp":1788539031846,"version":"build-2803163510"},"reference-count":136,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82474325"],"award-info":[{"award-number":["82474325"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005891","name":"State Administration of Traditional Chinese Medicine of The Peoples Republic of China","doi-asserted-by":"publisher","award":["GYZ-KJS-2025-104"],"award-info":[{"award-number":["GYZ-KJS-2025-104"]}],"id":[{"id":"10.13039\/501100005891","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.yexcr.2026.115147","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T06:44:41Z","timestamp":1786171481000},"page":"115147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The bone vicious cycle: How the microenvironment drives osteosarcoma progression"],"prefix":"10.1016","volume":"462","author":[{"given":"Liu","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haolong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinju","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5312-1806","authenticated-orcid":false,"given":"Wangzheqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhou","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.yexcr.2026.115147_bib1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41572-022-00409-y","article-title":"Osteosarcoma","volume":"8","author":"Beird","year":"2022","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"4","key":"10.1016\/j.yexcr.2026.115147_bib2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41388-022-02529-x","article-title":"The strategy and clinical relevance of in vitro models of MAP resistance in osteosarcoma: a systematic review","volume":"42","author":"Tippett","year":"2023","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.yexcr.2026.115147_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073817","article-title":"Recent and ongoing research into metastatic osteosarcoma treatments","volume":"23","author":"Harris","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115147_bib4","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12943-024-02105-9","article-title":"Advances on immunotherapy for osteosarcoma","volume":"23","author":"Yu","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.yexcr.2026.115147_bib5","article-title":"Single-cell RNA-seq reveals T cell exhaustion and immune response landscape in osteosarcoma","volume":"15","author":"Fan","year":"2024","journal-title":"Front. Immunol."},{"issue":"13","key":"10.1016\/j.yexcr.2026.115147_bib6","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.3390\/cancers17132117","article-title":"Immunosuppressive tumor microenvironment of osteosarcoma","volume":"17","author":"Taylor","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"10","key":"10.1016\/j.yexcr.2026.115147_bib7","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41577-019-0178-8","article-title":"Osteoimmunology: evolving concepts in bone-immune interactions in health and disease","volume":"19","author":"Tsukasaki","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.yexcr.2026.115147_bib8","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s00774-024-01539-x","article-title":"Crosstalk between bone and the immune system","volume":"42","author":"Okamoto","year":"2024","journal-title":"J. Bone Miner. Metabol."},{"issue":"2","key":"10.1016\/j.yexcr.2026.115147_bib9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/bph.15713","article-title":"Osteosarcoma mechanobiology and therapeutic targets","volume":"179","author":"Shoaib","year":"2022","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.yexcr.2026.115147_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23084373","article-title":"Osteocytes: their lacunocanalicular structure and mechanoresponses","volume":"23","author":"Moriishi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.yexcr.2026.115147_bib11","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.250103","article-title":"Bone marrow endosteum in homeostasis and metastasis","volume":"15","author":"Nakai","year":"2025","journal-title":"Open Biol."},{"key":"10.1016\/j.yexcr.2026.115147_bib12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.actbio.2025.04.057","article-title":"Insights into the osteosarcoma microenvironment: multiscale analysis of structural and mineral heterogeneity","volume":"199","author":"Rossi","year":"2025","journal-title":"Acta Biomater."},{"key":"10.1016\/j.yexcr.2026.115147_bib13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/164_2019_346","article-title":"Cytokines and bone: osteoimmunology","volume":"262","author":"Lorenzo","year":"2020","journal-title":"Handb. Exp. Pharmacol."},{"issue":"4","key":"10.1016\/j.yexcr.2026.115147_bib14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2183\/pjab.96.013","article-title":"Osteoimmunology - Bidirectional dialogue and inevitable union of the fields of bone and immunity","volume":"96","author":"Takayanagi","year":"2020","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"issue":"12","key":"10.1016\/j.yexcr.2026.115147_bib15","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1177\/1535370216648806","article-title":"Deciphering signaling networks in osteosarcoma pathobiology","volume":"241","author":"Adamopoulos","year":"2016","journal-title":"Exp. Biol. Med."},{"issue":"13","key":"10.1016\/j.yexcr.2026.115147_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13133128","article-title":"The effect of fluid flow shear stress and substrate stiffness on yes-associated protein (YAP) activity and osteogenesis in murine osteosarcoma cells","volume":"13","author":"Coughlin","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"13","key":"10.1016\/j.yexcr.2026.115147_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136865","article-title":"Osteosarcoma and metastasis associated bone Degradation-A tale of osteoclast and malignant cell cooperativity","volume":"22","author":"N\u00f8rregaard","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexcr.2026.115147_bib18","article-title":"Single-cell RNA sequencing revealed PPARG promoted osteosarcoma progression: based on osteoclast proliferation","volume":"15","author":"Sun","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115147_bib19","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3390\/cancers15010272","article-title":"Current state of immunotherapy and mechanisms of immune evasion in ewing sarcoma and Osteosarcoma","volume":"15","author":"Evdokimova","year":"2023","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.yexcr.2026.115147_bib20","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.bbadis.2015.05.010","article-title":"Mechanotransduction pathways in bone pathobiology","volume":"1852","author":"Spyropoulou","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.yexcr.2026.115147_bib21","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s13402-022-00674-9","article-title":"Calcium acts as a central player in melatonin antitumor activity in sarcoma cells","volume":"45","author":"S\u00e1nchez-S\u00e1nchez","year":"2022","journal-title":"Cell. Oncol."},{"issue":"3","key":"10.1016\/j.yexcr.2026.115147_bib22","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1152\/physrev.00012.2019","article-title":"Bone metastasis: mechanisms, therapies, and biomarkers","volume":"101","author":"Cl\u00e9zardin","year":"2021","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115147_bib23","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s40880-019-0425-1","article-title":"Interactions between cancer cells and bone microenvironment promote bone metastasis in prostate cancer","volume":"39","author":"Zhang","year":"2019","journal-title":"Cancer Commun."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115147_bib24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12967-025-06086-1","article-title":"Single-cell profiling of SLC family transporters: uncovering the role of SLC7A1 in osteosarcoma","volume":"23","author":"Liao","year":"2025","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115147_bib25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12929-024-00999-7","article-title":"Exploring the relationship between metabolism and immune microenvironment in osteosarcoma based on metabolic pathways","volume":"31","author":"Wu","year":"2024","journal-title":"J. Biomed. Sci."},{"issue":"17","key":"10.1016\/j.yexcr.2026.115147_bib26","article-title":"Osteosarcoma cell-derived migrasomes promote macrophage M2 polarization to aggravate osteosarcoma proliferation and metastasis","volume":"12","author":"Liu","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"1","key":"10.1016\/j.yexcr.2026.115147_bib27","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.2024941","article-title":"MerTK-mediated efferocytosis promotes immune tolerance and tumor progression in osteosarcoma through enhancing M2 polarization and PD-L1 expression","volume":"11","author":"Lin","year":"2022","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.yexcr.2026.115147_bib28","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1186\/s12967-025-06346-0","article-title":"Single-cell transcriptomics reveals metabolic remodeling and functional specialization in the immune microenvironment of bone tumors","volume":"23","author":"Chen","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.yexcr.2026.115147_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2021.109935","article-title":"Osteosarcoma-derived exosomal miR-501-3p promotes osteoclastogenesis and aggravates bone loss","volume":"82","author":"Lin","year":"2021","journal-title":"Cell. Signal."},{"issue":"8","key":"10.1016\/j.yexcr.2026.115147_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-011091","article-title":"Multiomics integration analysis identifies tumor cell-derived MIF as a therapeutic target and potentiates anti-PD-1 therapy in osteosarcoma","volume":"13","author":"Chen","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.yexcr.2026.115147_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.111601","article-title":"Substrate stiffness modulates osteogenic and adipogenic differentiation of osteosarcoma through PIEZO1 mediated signaling pathway","volume":"127","author":"Gao","year":"2025","journal-title":"Cell. Signal."},{"issue":"4","key":"10.1016\/j.yexcr.2026.115147_bib34","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s12013-023-01184-7","article-title":"Matrix stiffness regulated endoplasmic reticulum stress-mediated apoptosis of osteosarcoma cell through ras signal cascades","volume":"81","author":"Deng","year":"2023","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.yexcr.2026.115147_bib36","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jmbbm.2018.10.012","article-title":"Matrix stiffness regulates epithelial-mesenchymal transition via cytoskeletal remodeling and MRTF-A translocation in osteosarcoma cells","volume":"90","author":"Dai","year":"2019","journal-title":"J. Mech. Behav. Biomed. Mater."},{"key":"10.1016\/j.yexcr.2026.115147_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/pore.2021.609472","article-title":"Osteoclasts in tumor biology: metastasis and epithelial-mesenchymal-myeloid transition","volume":"27","author":"Behzatoglu","year":"2021","journal-title":"Pathol. Oncol. Res."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115147_bib38","doi-asserted-by":"crossref","DOI":"10.1080\/13510002.2025.2493556","article-title":"Rotenone inhibited osteosarcoma metastasis by modulating ZO-2 expression and location via the ROS\/Ca(2+)\/AMPK pathway","volume":"30","author":"Ma","year":"2025","journal-title":"Redox Rep."},{"key":"10.1016\/j.yexcr.2026.115147_bib39","first-page":"385","article-title":"Calcium-based biomaterials: unveiling features and expanding applications in osteosarcoma treatment","volume":"32","author":"Wu","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.yexcr.2026.115147_bib40","article-title":"Polydopamine-functionalized calcium-deficient hydroxyapatite 3D-printed scaffold with sustained doxorubicin release for synergistic chemo-photothermal therapy of osteosarcoma and accelerated bone regeneration","volume":"29","author":"Wang","year":"2024","journal-title":"Mater. Today Bio"},{"issue":"6","key":"10.1016\/j.yexcr.2026.115147_bib46","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.stemcr.2017.04.029","article-title":"cFOS-SOX9 axis reprograms bone marrow-derived mesenchymal stem cells into chondroblastic osteosarcoma","volume":"8","author":"He","year":"2017","journal-title":"Stem Cell Rep."},{"issue":"15","key":"10.1016\/j.yexcr.2026.115147_bib47","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1158\/1078-0432.CCR-24-0563","article-title":"Mapping the single-cell differentiation landscape of osteosarcoma","volume":"30","author":"Truong","year":"2024","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.yexcr.2026.115147_bib49","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/stem.2869","article-title":"Role of activator Protein-1 complex on the phenotype of human osteosarcomas generated from mesenchymal stem cells","volume":"36","author":"Gambera","year":"2018","journal-title":"Stem Cell."},{"issue":"41","key":"10.1016\/j.yexcr.2026.115147_bib131","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1038\/onc.2012.507","article-title":"The differentiation stage of p53-Rb-deficient bone marrow mesenchymal stem cells imposes the phenotype of in vivo sarcoma development","volume":"32","author":"Rubio","year":"2013","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.yexcr.2026.115147_bib59","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1158\/1535-7163.MCT-20-0591","article-title":"CSF1\/CSF1R signaling inhibitor pexidartinib (PLX3397) reprograms tumor-associated macrophages and stimulates T-cell infiltration in the sarcoma microenvironment","volume":"20","author":"Fujiwara","year":"2021","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.yexcr.2026.115147_bib60","article-title":"Osteosarcoma cell-derived small extracellular vesicles enhance osteoclastogenesis and bone resorption through transferring MicroRNA-19a-3p","volume":"11","author":"Luo","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115147_bib61","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/s42003-025-08409-w","article-title":"Single-cell analysis links DCUN1D5 to immune remodeling and cisplatin resistance in recurrent osteosarcoma","volume":"8","author":"Wu","year":"2025","journal-title":"Commun. Biol."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115147_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.652","article-title":"Destabilization of macrophage migration inhibitory factor by 4-IPP reduces NF-\u03baB\/P-TEFb complex-mediated c-Myb transcription to suppress osteosarcoma tumourigenesis","volume":"12","author":"Zheng","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.yexcr.2026.115147_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.116130","article-title":"Anti-osteoblastogenic, pro-inflammatory and pro-angiogenic effect of extracellular vesicles isolated from the human osteosarcoma cell line MNNG\/HOS","volume":"153","author":"Ucci","year":"2021","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.yexcr.2026.115147_bib64","article-title":"From bone homeostasis to skeletal metastasis and osteosarcoma: insights into osteoclast and osteoblast roles in bone remodelling and cancer","volume":"1881","author":"Kottmann","year":"2026","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.yexcr.2026.115147_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2025.101305","article-title":"Tackling myeloma bone disease: from pathophysiology to cutting-edge therapies","volume":"74","author":"Roux","year":"2025","journal-title":"Blood Rev."},{"issue":"11","key":"10.1016\/j.yexcr.2026.115147_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26114990","article-title":"RANKL drives bone metastasis in mammary cancer: protective effects of anti-resorptive treatments","volume":"26","author":"Gkikopoulou","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"19","key":"10.1016\/j.yexcr.2026.115147_bib67","doi-asserted-by":"crossref","first-page":"5102","DOI":"10.1158\/0008-5472.CAN-21-0524","article-title":"Targeting notch inhibitors to the myeloma bone marrow niche decreases tumor growth and bone destruction without gut toxicity","volume":"81","author":"Sabol","year":"2021","journal-title":"Cancer Res."},{"issue":"14","key":"10.1016\/j.yexcr.2026.115147_bib55","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1158\/1078-0432.CCR-16-2726","article-title":"Blocking tumor-educated MSC paracrine activity halts osteosarcoma progression","volume":"23","author":"Baglio","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115147_bib69","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41392-020-00414-1","article-title":"Rab22a-NeoF1 fusion protein promotes osteosarcoma lung metastasis through its secretion into exosomes","volume":"6","author":"Zhong","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"12","key":"10.1016\/j.yexcr.2026.115147_bib70","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1136\/gutjnl-2025-334851","article-title":"Extracellular vesicle-induced lipid dysregulation drives liver premetastatic niche formation in colorectal cancer","volume":"74","author":"Cao","year":"2025","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.yexcr.2026.115147_bib71","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1158\/2767-9764.CRC-23-0027","article-title":"Ewing sarcoma single-cell transcriptome analysis reveals functionally impaired antigen-presenting cells","volume":"3","author":"Visser","year":"2023","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.yexcr.2026.115147_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217636","article-title":"Lactate accumulation drives hepatocellular carcinoma metastasis through facilitating tumor-derived exosome biogenesis by Rab7A lactylation","volume":"627","author":"Jiang","year":"2025","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115147_bib73","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1186\/s12967-025-06334-4","article-title":"Colorectal cancer cells-derived exosomal miR-188-3p promotes liver metastasis by creating a pre-metastatic niche via activation of hepatic stellate cells","volume":"23","author":"Li","year":"2025","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.yexcr.2026.115147_bib74","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12197","article-title":"Melanoma-derived extracellular vesicles mediate lymphatic remodelling and impair tumour immunity in draining lymph nodes","volume":"11","author":"Leary","year":"2022","journal-title":"J. Extracell. Vesicles"},{"issue":"2","key":"10.1016\/j.yexcr.2026.115147_bib75","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.apsb.2021.08.011","article-title":"Inhibiting collagen I production and tumor cell colonization in the lung via miR-29a-3p loading of exosome-\/liposome-based nanovesicles","volume":"12","author":"Yan","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"13","key":"10.1016\/j.yexcr.2026.115147_bib76","doi-asserted-by":"crossref","first-page":"6454","DOI":"10.7150\/thno.113665","article-title":"Breaking the premetastatic niche barrier: the role of endothelial cells and therapeutic strategies","volume":"15","author":"Fang","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.yexcr.2026.115147_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1394284","article-title":"Unlocking the tumor-immune microenvironment in osteosarcoma: insights into the immune landscape and mechanisms","volume":"15","author":"Orrapin","year":"2024","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.yexcr.2026.115147_bib132","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.7150\/ijbs.109169","article-title":"Cancer-associated fibroblast-like cells promote osteosarcoma metastasis by upregulation of phosphoserine aminotransferase 1 and activation of the mTOR\/S6K pathway","volume":"21","author":"Feng","year":"2025","journal-title":"Int. J. Biol. Sci."},{"issue":"5","key":"10.1016\/j.yexcr.2026.115147_bib51","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1007\/s13402-024-00949-3","article-title":"Exploring the impact of PDGFD in osteosarcoma metastasis through single-cell sequencing analysis","volume":"47","author":"Huang","year":"2024","journal-title":"Cell. Oncol."},{"issue":"5","key":"10.1016\/j.yexcr.2026.115147_bib54","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/1878-0261.12189","article-title":"Bone marrow-derived mesenchymal stem cells promote invasiveness and transendothelial migration of osteosarcoma cells via a mesenchymal to amoeboid transition","volume":"12","author":"Pietrovito","year":"2018","journal-title":"Mol. Oncol."},{"issue":"4","key":"10.1016\/j.yexcr.2026.115147_bib56","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1080\/15592294.2019.1585177","article-title":"Epigenetic alterations in mesenchymal stem cells by osteosarcoma-derived extracellular vesicles","volume":"14","author":"Mannerstr\u00f6m","year":"2019","journal-title":"Epigenetics"},{"issue":"1","key":"10.1016\/j.yexcr.2026.115147_bib91","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12916-024-03319-w","article-title":"Single-cell and spatial transcriptomics reveal metastasis mechanism and microenvironment remodeling of lymph node in osteosarcoma","volume":"22","author":"Liu","year":"2024","journal-title":"BMC Med."},{"issue":"11","key":"10.1016\/j.yexcr.2026.115147_bib133","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166500","article-title":"Tumor-activated mesenchymal stromal cells promote osteosarcoma stemness and migratory potential via IL-6 secretion","volume":"11","author":"Cortini","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2026.115147_bib134","article-title":"A preclinical mouse model of osteosarcoma to define the extracellular vesicle-mediated communication between tumor and mesenchymal stem cells","volume":"135","author":"Lagerweij","year":"2018","journal-title":"J. Vis. Exp."},{"issue":"5","key":"10.1016\/j.yexcr.2026.115147_bib135","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.32604\/or.2024.054207","article-title":"Research progress on cancer-associated fibroblasts in osteosarcoma","volume":"33","author":"Feng","year":"2025","journal-title":"Oncol. Res."},{"issue":"20","key":"10.1016\/j.yexcr.2026.115147_bib136","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222011035","article-title":"Mesenchymal stem cells and extracellular vesicles in osteosarcoma pathogenesis and therapy","volume":"22","author":"Sarhadi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.yexcr.2026.115147_bib82","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.yexcr.2017.07.011","article-title":"Exosomes from osteosarcoma and normal osteoblast differ in proteomic cargo and immunomodulatory effects on T cells","volume":"358","author":"Troyer","year":"2017","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.yexcr.2026.115147_bib89","article-title":"Role of tumor-derived exosomes and immune cells in osteosarcoma progression and targeted therapy","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexcr.2026.115147_bib95","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2025.1718941","article-title":"Single-cell dissection of PTM-related networks reveals an immunosuppressed osteosarcoma ecosystem","volume":"12","author":"Chen","year":"2025","journal-title":"Front. Mol. Biosci."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115147_bib93","article-title":"Non-viral TcBuster transposon engineering of CD70-CAR natural killer cells for the treatment of osteosarcoma","volume":"34","author":"Robbins","year":"2026","journal-title":"Mol. Ther. Oncol."},{"key":"10.1016\/j.yexcr.2026.115147_bib94","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2021.672361","article-title":"Adoptive natural killer cell immunotherapy for canine osteosarcoma","volume":"8","author":"Kisseberth","year":"2021","journal-title":"Front. Vet. Sci."},{"issue":"20","key":"10.1016\/j.yexcr.2026.115147_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21207595","article-title":"Targeting mechanotransduction in osteosarcoma: a comparative oncology perspective","volume":"21","author":"Luu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexcr.2026.115147_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.152272","article-title":"Targeting mechanotransduction in osteosarcoma","volume":"777","author":"He","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"18","key":"10.1016\/j.yexcr.2026.115147_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26188816","article-title":"A 'Spicy' mechanotransduction switch: capsaicin-activated TRPV1 receptor modulates osteosarcoma cell behavior and drug sensitivity","volume":"26","author":"Buglione","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.yexcr.2026.115147_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.seminoncol.2025.152390","article-title":"Multiple myeloma: insights into underlying mechanisms, advances in diagnostic and therapeutic modalities","volume":"52","author":"Yadav","year":"2025","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.yexcr.2026.115147_bib42","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.imlet.2018.04.007","article-title":"The link between bone microenvironment and immune cells in multiple myeloma: emerging role of CD38","volume":"205","author":"Bolzoni","year":"2019","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.yexcr.2026.115147_bib43","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.3389\/fimmu.2018.01822","article-title":"Osteoclast immunosuppressive effects in multiple myeloma: role of programmed cell death ligand 1","volume":"9","author":"Tai","year":"2018","journal-title":"Front. Immunol."},{"issue":"24","key":"10.1016\/j.yexcr.2026.115147_bib44","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.21037\/atm-22-5856","article-title":"Development of personalized classifier based on metastasis and the immune microenvironment to predict the prognosis of osteosarcoma patients","volume":"10","author":"Zhang","year":"2022","journal-title":"Ann. Transl. Med."},{"issue":"12","key":"10.1016\/j.yexcr.2026.115147_bib45","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1530\/EOR-2025-0021","article-title":"Research advances in the role of osteoblasts and their derivatives in the development, recurrence, and distant metastasis of malignant bone tumors: a narrative review","volume":"10","author":"Huang","year":"2025","journal-title":"EFORT Open Rev."},{"issue":"7","key":"10.1016\/j.yexcr.2026.115147_bib48","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1158\/0008-5472.CAN-23-1307","article-title":"Osteosarcoma cells secrete CXCL14 that activates integrin \u03b111\u03b21 on fibroblasts to form a lung metastatic niche","volume":"84","author":"Xu","year":"2024","journal-title":"Cancer Res."},{"issue":"22","key":"10.1016\/j.yexcr.2026.115147_bib50","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1158\/0008-5472.CAN-24-3452","article-title":"KDM6 demethylases contribute to EWSR1::FLI1-Driven oncogenic reprogramming in ewing sarcoma","volume":"85","author":"Figuerola-Bou","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2026.115147_bib52","article-title":"High GNG4 predicts adverse prognosis for osteosarcoma: bioinformatics prediction and experimental verification","volume":"13","author":"Jiang","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.yexcr.2026.115147_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2025.100662","article-title":"The METTL3\/TGF-\u03b21 signaling axis promotes osteosarcoma progression by inducing MSC differentiation into CAFs via m(6)A modification","volume":"51","author":"Qi","year":"2025","journal-title":"J. Bone Oncol."},{"issue":"20","key":"10.1016\/j.yexcr.2026.115147_bib57","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1158\/1078-0432.CCR-23-4097","article-title":"Tumor-secreted extracellular vesicles counteract therapy response by triggering inflammatory mesenchymal stem cell development","volume":"30","author":"Massaro","year":"2024","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.yexcr.2026.115147_bib58","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1158\/2767-9764.CRC-24-0371","article-title":"Osteosarcoma exosome priming of primary human lung fibroblasts induces an immune modulatory and protumorigenic phenotype","volume":"5","author":"Palmer","year":"2025","journal-title":"Cancer Res. Commun."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115147_bib77","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/s41598-023-49770-2","article-title":"A CIC-related-epigenetic factors-based model associated with prediction, the tumor microenvironment and drug sensitivity in osteosarcoma","volume":"14","author":"Yu","year":"2024","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.yexcr.2026.115147_bib78","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3892\/ol.2025.15189","article-title":"Risk score model with two immune infiltration-related long non-coding RNAs to predict prognosis in patients with osteosarcoma","volume":"30","author":"Zeng","year":"2025","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115147_bib79","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/s41467-020-14646-w","article-title":"Immuno-genomic landscape of osteosarcoma","volume":"11","author":"Wu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexcr.2026.115147_bib80","article-title":"Divergent HLA variations and heterogeneous expression but recurrent HLA loss-of- heterozygosity and common HLA-B and TAP transcriptional silencing across advanced pediatric solid cancers","volume":"14","author":"Lim","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115147_bib81","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12967-023-04794-0","article-title":"Construction of an ER stress-related prognostic signature for predicting prognosis and screening the effective anti-tumor drug in osteosarcoma","volume":"22","author":"Chen","year":"2024","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115147_bib83","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1747677","article-title":"Exosomal communication by metastatic osteosarcoma cells modulates alveolar macrophages to an M2 tumor-promoting phenotype and inhibits tumoricidal functions","volume":"9","author":"Wolf-Dennen","year":"2020","journal-title":"Oncoimmunology"},{"issue":"6","key":"10.1016\/j.yexcr.2026.115147_bib84","article-title":"Extracellular vesicles from highly metastatic osteosarcoma cells induce pro-tumorigenic macrophage phenotypes","volume":"8","author":"Griffin","year":"2024","journal-title":"Adv Biol (Weinh)"},{"issue":"1","key":"10.1016\/j.yexcr.2026.115147_bib85","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10585-022-10192-5","article-title":"PITX1 suppresses osteosarcoma metastasis through exosomal LINC00662-mediated M2 macrophage polarization","volume":"40","author":"Zhang","year":"2023","journal-title":"Clin. Exp. Metastasis"},{"issue":"1","key":"10.1016\/j.yexcr.2026.115147_bib86","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s12935-024-03488-x","article-title":"The sEVs miR-487a\/Notch2\/GATA3 axis promotes osteosarcoma lung metastasis by inducing macrophage polarization toward the M2-subtype","volume":"24","author":"Wang","year":"2024","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.yexcr.2026.115147_bib87","article-title":"Osteosarcoma cell-derived exosomal ELFN1-AS1 mediates macrophage M2 polarization via sponging miR-138-5p and miR-1291 to promote the tumorgenesis of osteosarcoma","volume":"12","author":"Wang","year":"2022","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.yexcr.2026.115147_bib88","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/kjm2.12623","article-title":"Exosomal miR-181a-5p derived from SAOS-2 cells promotes macrophages M2 polarization by targeting RORA","volume":"39","author":"Wang","year":"2023","journal-title":"Kaohsiung J. Med. Sci."},{"issue":"3","key":"10.1016\/j.yexcr.2026.115147_bib90","article-title":"Methionine intervention induces PD-L1 expression to enhance the immune checkpoint therapy response in MTAP-Deleted osteosarcoma","volume":"6","author":"Mu","year":"2025","journal-title":"Cell Rep. Med."},{"issue":"20","key":"10.1016\/j.yexcr.2026.115147_bib92","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1097\/CM9.0000000000002800","article-title":"Research progress in the mechanism and treatment of osteosarcoma","volume":"136","author":"Bian","year":"2023","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"10.1016\/j.yexcr.2026.115147_bib96","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1186\/s13046-019-1506-3","article-title":"ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity","volume":"38","author":"Zucchini","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.yexcr.2026.115147_bib97","doi-asserted-by":"crossref","DOI":"10.3390\/cells11081361","article-title":"Verteporfin inhibits the progression of spontaneous osteosarcoma caused by Trp53 and Rb1 deficiency in Ctsk-Expressing cells via impeding hippo pathway","volume":"11","author":"Li","year":"2022","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.yexcr.2026.115147_bib98","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3892\/ol.2021.12985","article-title":"Verteporfin suppresses osteosarcoma progression by targeting the hippo signaling pathway","volume":"22","author":"Yang","year":"2021","journal-title":"Oncol. Lett."},{"issue":"12","key":"10.1016\/j.yexcr.2026.115147_bib99","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12123847","article-title":"The YAP\/TEAD axis as a new therapeutic target in osteosarcoma: effect of verteporfin and CA3 on primary tumor growth","volume":"12","author":"Morice","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.yexcr.2026.115147_bib100","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/1440-1681.13209","article-title":"Calcium-sensing receptor activating ERK1\/2 and PI3K-Akt pathways to induce the proliferation of osteosarcoma cells","volume":"47","author":"Zhao","year":"2020","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"4","key":"10.1016\/j.yexcr.2026.115147_bib101","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s11914-023-00803-9","article-title":"Advances in osteosarcoma","volume":"21","author":"Panez-Toro","year":"2023","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.yexcr.2026.115147_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107611","article-title":"New insights into molecular and cellular mechanisms of zoledronate in human osteosarcoma","volume":"214","author":"Lu","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.yexcr.2026.115147_bib103","article-title":"Zoledronic acid enhanced the antitumor effect of cisplatin on orthotopic osteosarcoma by ROS-PI3K\/AKT signaling and attenuated osteolysis","volume":"2021","author":"Liu","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115147_bib105","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41416-022-01764-z","article-title":"Morpholino-driven blockade of Dkk-1 in osteosarcoma inhibits bone damage and tumour expansion by multiple mechanisms","volume":"127","author":"Pan","year":"2022","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.yexcr.2026.115147_bib106","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1038\/s41598-024-84037-4","article-title":"Antisense mediated blockade of dickkopf 1 attenuates tumor survival, metastases and bone damage in experimental osteosarcoma","volume":"15","author":"Haskell","year":"2025","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.yexcr.2026.115147_bib107","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1158\/1535-7163.MCT-24-0744","article-title":"Inhibition of DKK-1 by WAY262611 inhibits osteosarcoma metastasis","volume":"24","author":"Tal","year":"2025","journal-title":"Mol. Cancer Therapeut."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115147_bib108","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41419-022-05545-7","article-title":"Nuclear receptor modulators inhibit osteosarcoma cell proliferation and tumour growth by regulating the mTOR signaling pathway","volume":"14","author":"Yuan","year":"2023","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115147_bib127","article-title":"Bone-targeted fluoropeptide nanoparticle inhibits NF-\u03baB signaling to treat osteosarcoma and tumor-induced bone destruction","volume":"12","author":"Li","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"7","key":"10.1016\/j.yexcr.2026.115147_bib112","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012269","article-title":"Enhanced antitumor immunity of VNP20009-CCL2-CXCL9 via the cGAS\/STING axis in osteosarcoma lung metastasis","volume":"13","author":"Liu","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"8","key":"10.1016\/j.yexcr.2026.115147_bib113","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1021\/acsbiomaterials.5c00333","article-title":"BSA-LDHs-cGAMP in situ sensitization of osteosarcoma: enhancing antitumor efficacy with CD40 agonist antibodies","volume":"11","author":"Yan","year":"2025","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.yexcr.2026.115147_bib114","first-page":"450","article-title":"Mitochondria-targeted MXene@MnO(2)-TPP nanoheterostructures for synergistic enhancement of sonodynamic therapy and immunotherapy in osteosarcoma","volume":"54","author":"Zeng","year":"2025","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.yexcr.2026.115147_bib115","article-title":"Make it STING: nanotechnological approaches for activating cGAS\/STING as an immunomodulatory node in osteosarcoma","volume":"15","author":"O'Donoghue","year":"2024","journal-title":"Front. Immunol."},{"issue":"22","key":"10.1016\/j.yexcr.2026.115147_bib116","doi-asserted-by":"crossref","DOI":"10.3390\/cells13221862","article-title":"CD47 in osteosarcoma: correlation with metastasis and macrophage-mediated phagocytosis","volume":"13","author":"Ko","year":"2024","journal-title":"Cells"},{"issue":"27","key":"10.1016\/j.yexcr.2026.115147_bib117","doi-asserted-by":"crossref","first-page":"23662","DOI":"10.18632\/oncotarget.4282","article-title":"CD47 blockade inhibits tumor progression human osteosarcoma in xenograft models","volume":"6","author":"Xu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.yexcr.2026.115147_bib118","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1608375","article-title":"STAT3 inhibition in combination with CD47 blockade inhibits osteosarcoma lung metastasis","volume":"16","author":"Shrestha","year":"2025","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.yexcr.2026.115147_bib119","doi-asserted-by":"crossref","first-page":"691","DOI":"10.32604\/or.2023.030767","article-title":"Codelivery of anti-CD47 antibody and chlorin e6 using a dual pH-sensitive nanodrug for photodynamic immunotherapy of osteosarcoma","volume":"32","author":"Xiao","year":"2024","journal-title":"Oncol. Res."},{"issue":"11","key":"10.1016\/j.yexcr.2026.115147_bib122","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-011976","article-title":"HSP47 inhibition-induced CD155 expression through TRAF2 deubiquitination promotes tumor immune evasion","volume":"13","author":"Mou","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"8","key":"10.1016\/j.yexcr.2026.115147_bib104","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S1470-2045(16)30096-1","article-title":"Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial","volume":"17","author":"Piperno-Neumann","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.yexcr.2026.115147_bib109","article-title":"The malignant dialogue between cancer-associated fibroblasts and osteosarcoma cells: microenvironment-mediated drug resistance and therapeutic targets","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexcr.2026.115147_bib110","article-title":"Cancer-associated fibroblasts in osteosarcoma: key players in immune escape and targeted therapy","volume":"16","author":"Fan","year":"2025","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.yexcr.2026.115147_bib111","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1002\/ijc.30841","article-title":"A phase II trial evaluating the feasibility of adding bevacizumab to standard osteosarcoma therapy","volume":"141","author":"Navid","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.yexcr.2026.115147_bib120","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1123065","article-title":"The interaction between osteosarcoma and other cells in the bone microenvironment: from mechanism to clinical applications","volume":"11","author":"Zeng","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.yexcr.2026.115147_bib121","volume":"15","author":"Nirala","year":"2023"},{"issue":"1","key":"10.1016\/j.yexcr.2026.115147_bib123","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s11658-025-00724-8","article-title":"Troxerutin suppresses the stemness of osteosarcoma via the CD155\/SRC\/\u03b2-catenin signaling axis","volume":"30","author":"Chen","year":"2025","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.yexcr.2026.115147_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2025.101266","article-title":"Dual CDK4\/6-PI3K\/mTOR inhibition reinforces cytostatic programs and tumor control in preclinical models of primary and metastatic osteosarcoma","volume":"72","author":"Barghi","year":"2026","journal-title":"Neoplasia"},{"issue":"2","key":"10.1016\/j.yexcr.2026.115147_bib125","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.202300268","article-title":"Targeted nanoparticles based on alendronate polyethylene glycol conjugated chitosan for the delivery of siRNA and curcumin for bone metastasized breast cancer applications","volume":"24","author":"Mushtaq","year":"2024","journal-title":"Macromol. Biosci."},{"issue":"8","key":"10.1016\/j.yexcr.2026.115147_bib126","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1021\/acs.biomac.5c00409","article-title":"Surface-engineered porous silicon nanoparticles for targeted osteosarcoma therapy","volume":"26","author":"Abdelmoneem","year":"2025","journal-title":"Biomacromolecules"},{"issue":"43","key":"10.1016\/j.yexcr.2026.115147_bib128","doi-asserted-by":"crossref","first-page":"29864","DOI":"10.1021\/acsnano.4c10053","article-title":"Bone destruction-chemotactic osteoprogenitor cells deliver liposome nanomedicines for the treatment of osteosarcoma and osteoporosis","volume":"18","author":"Chen","year":"2024","journal-title":"ACS Nano"},{"issue":"34","key":"10.1016\/j.yexcr.2026.115147_bib129","doi-asserted-by":"crossref","first-page":"30786","DOI":"10.1021\/acsnano.5c00223","article-title":"Immune-modulating dual-targeted nanomaterials for low-temperature photothermal-photodynamic-chemodynamic therapy of osteosarcoma targeting tumor and endothelial cells","volume":"19","author":"Pan","year":"2025","journal-title":"ACS Nano"},{"issue":"33","key":"10.1016\/j.yexcr.2026.115147_bib130","article-title":"A Se Nanoparticle\/MgFe-LDH composite nanosheet as a multifunctional platform for osteosarcoma eradication, antibacterial and bone reconstruction","volume":"11","author":"Bian","year":"2024","journal-title":"Adv. Sci. (Weinh.)"}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482726002648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482726002648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:09:12Z","timestamp":1788538152000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482726002648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":136,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0014482726002648"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2026.115147","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The bone vicious cycle: How the microenvironment drives osteosarcoma progression","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2026.115147","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115147"}}